2 indigenous Covid vaccine candidates completed phase 1 trials;

Phase 2/3 human trials on the Oxford-AstraZeneca vaccine candidate by the Serum Institute of India (SII) were also underway in the country until last week, when they had to be paused after a trial participant in the UK developed an unexplained adverse reaction.

from Hindustan Times - india https://ift.tt/3mmvnEm
via IFTTT